Sodium Nitroprusside: NO–cGMP Vasodilation, Hypertensive Emergencies and Cyanide Toxicity

Evidence-informed pharmacology monograph updated 10 November 2026. Educational content, not a substitute for patient-specific assessment, institutional protocols or current product labeling. Overview and chemistry Sodium nitroprusside is an ultra-short-acting intravenous vasodilator used for carefully selected hypertensive emergencies, perioperative controlled hypotension and acute heart failure with marked afterload elevation. It is a coordination complex commonly written…

Read Full News

Hydralazine: Direct Arteriolar Vasodilation, HFrEF Combination and Lupus Risk

Evidence-informed pharmacology monograph updated 10 November 2026. Educational content, not a substitute for patient-specific assessment, institutional protocols or current product labeling. Overview and chemical identity Hydralazine is an orally and parenterally available direct arteriolar vasodilator used in selected hypertension settings and combined with isosorbide dinitrate for certain HFrEF patients. Its chemical identity is 1-hydrazinophthalazine, formula…

Read Full News

Nimodipine: Aneurysmal Subarachnoid Hemorrhage, Enteral Dosing and Safety

Evidence-informed pharmacology monograph updated 10 November 2026. Educational content, not a substitute for patient-specific assessment, institutional protocols or current product labeling. Overview and correct indication Nimodipine is a lipophilic dihydropyridine L-type calcium channel blocker with an established role in improving neurologic outcomes following aneurysmal subarachnoid hemorrhage (aSAH). Although its vascular effects may reduce calcium-dependent vasoconstriction,…

Read Full News

Nifedipine: Dihydropyridine Calcium Blockade, Extended-Release Therapy and Precautions

Evidence-informed pharmacology monograph updated 10 November 2026. Educational content, not a substitute for patient-specific assessment, institutional protocols or current product labeling. Overview and correct chemistry Nifedipine is a dihydropyridine calcium channel blocker used in hypertension and chronic angina and for selected pregnancy-related and vasospastic disorders under protocol. The chemical formula is C17H18N2O6, and its aromatic…

Read Full News

Valsartan: AT1 Receptor Blockade, Heart Failure, Renal Monitoring and Fetal Toxicity

Evidence-informed pharmacology monograph updated 10 November 2026. Educational content, not a substitute for patient-specific assessment, institutional protocols or current product labeling. Overview and chemical identity Valsartan is a selective nonpeptide angiotensin II type 1 (AT1) receptor antagonist (ARB), used for hypertension, certain heart-failure regimens and post-myocardial-infarction left ventricular dysfunction. Its correct empirical formula is C24H29N5O3;…

Read Full News

Telmisartan Monograph: AT1 Receptor Blockade, Cardiovascular Prevention and Renal Safety

Evidence-informed pharmacology monograph updated 10 November 2026. For education only; use current local labeling, clinical guidance and individual assessment. Overview and classification Telmisartan is a nonpeptide angiotensin II receptor blocker (ARB), containing two benzimidazole groups and a biphenyl carboxylic acid moiety; the previous article’s elaborate imidazopyrimidine/piperazine chemical name was incorrect. Telmisartan antagonizes angiotensin II AT1…

Read Full News

Acetazolamide Monograph: Carbonic Anhydrase Inhibition, Altitude Illness and Acidosis

Evidence-informed pharmacology monograph updated 10 November 2026. For education only; use current local labeling, clinical guidance and individual assessment. Overview Acetazolamide is a systemic sulfonamide carbonic anhydrase inhibitor, used for altitude illness prophylaxis/treatment, selected glaucoma indications, intracranial hypertension, epilepsy and certain edema or alkalosis scenarios. It is a relatively weak diuretic compared with loop diuretics…

Read Full News

Dextromethorphan Monograph: Cough Suppression, CYP2D6 and Serotonin Syndrome

Evidence-informed pharmacology monograph updated 10 November 2026. For education only; use current local labeling, clinical guidance and individual assessment. Overview and structure Dextromethorphan is a synthetic dextrorotatory morphinan used as a centrally acting nonopioid antitussive at recommended doses. It is structurally related to opioid compounds but has little clinically meaningful mu-opioid agonist activity at usual…

Read Full News

Acetylcysteine Monograph: Glutathione Replenishment, Mucolysis and Paracetamol Antidote

Evidence-informed pharmacology monograph updated 10 November 2026. For education only; use current local labeling, clinical guidance and individual assessment. Overview N-acetylcysteine (NAC; acetylcysteine) is used as an antidote for acetaminophen/paracetamol poisoning and as a mucolytic in selected respiratory conditions. Mechanisms include supplying cysteine for glutathione synthesis and reducing disulfide bonds in mucoproteins. Evidence for unapproved…

Read Full News

Fluticasone Monograph: Inhaled, Intranasal and Topical Corticosteroid Safety

Evidence-informed pharmacology monograph updated 10 November 2026. For education only; use current local labeling, clinical guidance and individual assessment. Overview and formulations Fluticasone is a potent synthetic glucocorticoid available as different ester formulations, including fluticasone propionate and fluticasone furoate, with inhaled, intranasal and topical products. They are not interchangeable milligram-for-milligram. Inhaled corticosteroids (ICS) control airway…

Read Full News